ABBOTT LABORATORIES, v. MYLAN PHARMACEUTICALS, INC.,
15 So. 3d 642 (Fla. Dist. Ct. App. 2009)
. . . Section 465.0251(1) removes a generic drug from the NDF if the generic drug is “A” rated as therapeutically . . . Because the ALJ erred in interpreting section 465.0251(1) to apply to editions of the Orange Book subsequent . . . Section 465.0251, Florida Statutes (2007), permits removal from the NDF under specific circumstances . . . Although subsection (1) of section 465.0251 requires removal of a drug product from the NDF without an . . . Section 165.0251
We now turn to the merits of the parties’ arguments with respect to section 465.0251 . . .
